HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective mRNA degradation by polynucleotide phosphorylase in cold shock adaptation in Escherichia coli.

Abstract
Upon cold shock, Escherichia coli cell growth transiently stops. During this acclimation phase, specific cold shock proteins (CSPs) are highly induced. At the end of the acclimation phase, their synthesis is reduced to new basal levels, while the non-cold shock protein synthesis is resumed, resulting in cell growth reinitiation. Here, we report that polynucleotide phosphorylase (PNPase) is required to repress CSP production at the end of the acclimation phase. A pnp mutant, upon cold shock, maintained a high level of CSPs even after 24 h. PNPase was found to be essential for selective degradation of CSP mRNAs at 15 degrees C. In a poly(A) polymerase mutant and a CsdA RNA helicase mutant, CSP expression upon cold shock was significantly prolonged, indicating that PNPase in concert with poly(A) polymerase and CsdA RNA helicase plays a critical role in cold shock adaptation.
AuthorsK Yamanaka, M Inouye
JournalJournal of bacteriology (J Bacteriol) Vol. 183 Issue 9 Pg. 2808-16 (May 2001) ISSN: 0021-9193 [Print] United States
PMID11292800 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Bacterial Proteins
  • Escherichia coli Proteins
  • RNA, Messenger
  • Transcription Factors
  • cold shock protein CS7.4, Bacteria
  • Polyribonucleotide Nucleotidyltransferase
  • deaD protein, E coli
  • DEAD-box RNA Helicases
  • RNA Helicases
Topics
  • Adaptation, Biological
  • Bacterial Proteins (genetics, metabolism)
  • Cold Temperature
  • DEAD-box RNA Helicases
  • Down-Regulation
  • Escherichia coli (metabolism, physiology)
  • Escherichia coli Proteins
  • Mutation
  • Polyribonucleotide Nucleotidyltransferase (genetics, physiology)
  • RNA Helicases (genetics, physiology)
  • RNA, Messenger (metabolism)
  • Time Factors
  • Transcription Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: